249 related articles for article (PubMed ID: 24531491)
1. Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease.
Chou CY; Lai HY; Chen HY; Cheng SC; Cheng KW; Chou YW
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):572-81. PubMed ID: 24531491
[TBL] [Abstract][Full Text] [Related]
2. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.
Lindner HA; Fotouhi-Ardakani N; Lytvyn V; Lachance P; Sulea T; Ménard R
J Virol; 2005 Dec; 79(24):15199-208. PubMed ID: 16306591
[TBL] [Abstract][Full Text] [Related]
3. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.
Barretto N; Jukneliene D; Ratia K; Chen Z; Mesecar AD; Baker SC
J Virol; 2005 Dec; 79(24):15189-98. PubMed ID: 16306590
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
[TBL] [Abstract][Full Text] [Related]
5. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme.
Ratia K; Saikatendu KS; Santarsiero BD; Barretto N; Baker SC; Stevens RC; Mesecar AD
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5717-22. PubMed ID: 16581910
[TBL] [Abstract][Full Text] [Related]
6. Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
Ratia K; Kilianski A; Baez-Santos YM; Baker SC; Mesecar A
PLoS Pathog; 2014 May; 10(5):e1004113. PubMed ID: 24854014
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression.
Bailey-Elkin BA; Knaap RC; Johnson GG; Dalebout TJ; Ninaber DK; van Kasteren PB; Bredenbeek PJ; Snijder EJ; Kikkert M; Mark BL
J Biol Chem; 2014 Dec; 289(50):34667-82. PubMed ID: 25320088
[TBL] [Abstract][Full Text] [Related]
8. SARS hCoV papain-like protease is a unique Lys48 linkage-specific di-distributive deubiquitinating enzyme.
Békés M; Rut W; Kasperkiewicz P; Mulder MP; Ovaa H; Drag M; Lima CD; Huang TT
Biochem J; 2015 Jun; 468(2):215-26. PubMed ID: 25764917
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.
Lee H; Lei H; Santarsiero BD; Gatuz JL; Cao S; Rice AJ; Patel K; Szypulinski MZ; Ojeda I; Ghosh AK; Johnson ME
ACS Chem Biol; 2015 Jun; 10(6):1456-65. PubMed ID: 25746232
[TBL] [Abstract][Full Text] [Related]
10. Structural view and substrate specificity of papain-like protease from avian infectious bronchitis virus.
Kong L; Shaw N; Yan L; Lou Z; Rao Z
J Biol Chem; 2015 Mar; 290(11):7160-8. PubMed ID: 25609249
[TBL] [Abstract][Full Text] [Related]
11. Structural and mutational analysis of the interaction between the Middle-East respiratory syndrome coronavirus (MERS-CoV) papain-like protease and human ubiquitin.
Lei J; Hilgenfeld R
Virol Sin; 2016 Aug; 31(4):288-99. PubMed ID: 27245450
[TBL] [Abstract][Full Text] [Related]
12. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
Báez-Santos YM; St John SE; Mesecar AD
Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
[TBL] [Abstract][Full Text] [Related]
13. A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.
Patchett S; Lv Z; Rut W; Békés M; Drag M; Olsen SK; Huang TT
Cell Rep; 2021 Sep; 36(13):109754. PubMed ID: 34547223
[TBL] [Abstract][Full Text] [Related]
14. MERS-CoV papain-like protease has deISGylating and deubiquitinating activities.
Mielech AM; Kilianski A; Baez-Santos YM; Mesecar AD; Baker SC
Virology; 2014 Feb; 450-451():64-70. PubMed ID: 24503068
[TBL] [Abstract][Full Text] [Related]
15. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.
Kandeel M; Kitade Y; Fayez M; Venugopala KN; Ibrahim A
J Med Virol; 2021 Mar; 93(3):1581-1588. PubMed ID: 32902889
[TBL] [Abstract][Full Text] [Related]
16. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity.
Harcourt BH; Jukneliene D; Kanjanahaluethai A; Bechill J; Severson KM; Smith CM; Rota PA; Baker SC
J Virol; 2004 Dec; 78(24):13600-12. PubMed ID: 15564471
[TBL] [Abstract][Full Text] [Related]
17. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.
Báez-Santos YM; Mielech AM; Deng X; Baker S; Mesecar AD
J Virol; 2014 Nov; 88(21):12511-27. PubMed ID: 25142582
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features.
Lei J; Mesters JR; Drosten C; Anemüller S; Ma Q; Hilgenfeld R
Antiviral Res; 2014 Sep; 109():72-82. PubMed ID: 24992731
[TBL] [Abstract][Full Text] [Related]
19. Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease.
Lindner HA; Lytvyn V; Qi H; Lachance P; Ziomek E; Ménard R
Arch Biochem Biophys; 2007 Oct; 466(1):8-14. PubMed ID: 17692280
[TBL] [Abstract][Full Text] [Related]
20. Papain-like protease 1 from transmissible gastroenteritis virus: crystal structure and enzymatic activity toward viral and cellular substrates.
Wojdyla JA; Manolaridis I; van Kasteren PB; Kikkert M; Snijder EJ; Gorbalenya AE; Tucker PA
J Virol; 2010 Oct; 84(19):10063-73. PubMed ID: 20668092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]